Mark Mcdade is of Icosavax, Inc.. Currently has a direct ownership of 0 shares of ICVX, which is worth approximately $0. The most recent transaction as insider was on Feb 19, 2024, when has been sold 55,786 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

MARK MCDADE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 19 2024
SELL
Disposition due to a tender of shares in a change of control transaction
-
55,786 Reduced 100.0%
0 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
5,543 Added 9.04%
55,786 Common Stock
Apr 01 2022
BUY
Open market or private purchase
$299,797 $7.1 p/Share
42,225 Added 45.66%
50,243 Common Stock

Also insider at

TALS
Talaris Therapeutics, Inc. Healthcare
MM

Mark Mcdade

Bellevue, WA

Track Institutional and Insider Activities on ICVX

Follow Icosavax, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICVX shares.

Notify only if

Insider Trading

Get notified when an Icosavax, Inc. insider buys or sells ICVX shares.

Notify only if

News

Receive news related to Icosavax, Inc.

Track Activities on ICVX